Jagruthi Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 2.35 Cr
- Paid Up Capital ₹ 2.17 Cr
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 0.08%
About Jagruthi Bio-Tech
Jagruthi Bio-Tech Private Limited (JBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 2010 and has a history of 14 years and seven months. Its registered office is in Godavari, Andhra Pradesh, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.35 Cr and a paid-up capital of Rs 2.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Narayana Yejna and Suvarchala Akella serve as directors at the Company.
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15500AP2010PTC068989
- Company No.
068989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Jagruthi Bio-Tech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Narayana Yejna  | Director | 07-Sep-2014 | Current |
| Suvarchala Akella | Director | 07-Sep-2014 | Current |
Financial Performance of Jagruthi Bio-Tech.
Jagruthi Bio-Tech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jagruthi Bio-Tech?
In 2018, Jagruthi Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Varahagiri Industries Private LimitedNarayana Yejna and Suvarchala Akella are mutual person
- Everest Bio Sciences Limited
Narayana Yejna and Suvarchala Akella are mutual person
- Varahi Industries Private Limited
Narayana Yejna and Suvarchala Akella are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jagruthi Bio-Tech?
Unlock and access historical data on people associated with Jagruthi Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagruthi Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagruthi Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
